Premium
Xenon Pharmaceuticals Inc (XENE)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Founded in 1984, Xilinx is the leader in FPGAs by market share. Its chips are critical in the performance of various devices in the communications, data processing, industrial, consumer, and automotive markets. Founded in 1984, Xilinx is the leader in FPGAs by market share. Its chips are critical in the performance of various devices in the communications, data processing, industrial, consumer, and automotive markets.
– Topline data from the first Phase 3 FOS study anticipated in H2 2025 representing major milestone in support of NDA filing and potential launch of azetukalner – First of three planned Phase 3...
VANCOUVER, British Columbia and BOSTON, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering...
– OLE data shows sustained monthly reduction in seizure frequency, impressive seizure freedom rates, and consistent AE safety profile suggesting long-term efficacy and tolerability of azetukalner...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 39.98 | 43.99 | 39.435 | 535383 | 40.19621102 | CS |
| 4 | -0.55 | -1.35701949173 | 40.53 | 43.99 | 36.9 | 429231 | 39.69888181 | CS |
| 12 | -5.27 | -11.6464088398 | 45.25 | 45.45 | 36.9 | 415313 | 40.2725255 | CS |
| 26 | -1.4801 | -3.56993832625 | 41.4601 | 46 | 36 | 370816 | 40.50670761 | CS |
| 52 | -5.93 | -12.9165759094 | 45.91 | 50.99 | 35.53 | 382805 | 41.34125296 | CS |
| 156 | 10.98 | 37.8620689655 | 29 | 50.99 | 24.94 | 422233 | 37.47366153 | CS |
| 260 | 25.29 | 172.157930565 | 14.69 | 50.99 | 7 | 433856 | 32.37519953 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
